|
CAS-Nr. | 110025-28-0 |
Bezeichnung: | |
Englisch Name: | N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) |
Synonyma: | 4OHNDtam;E/Z Endoxifen;4-hydroxy-N-desmethyltamoxifen;N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture);4-[1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol;4-[(E)-1-[4-(2-methylaminoethoxy)phenyl]-2-phenyl-but-1-enyl]phenol;4-[(Z)-1-[4-[2-(Methylamino)ethoxy]phenyl]-2-phenyl-1-butenyl]phenol;N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture)
see H938500 |
CBNumber: | CB61176584 |
Summenformel: | C25H27NO2 |
Molgewicht: | 373.493 |
MOL-Datei: | 110025-28-0.mol |
|
|
|
|
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) physikalisch-chemischer Eigenschaften |
|
storage temp. : |
-20°C Freezer |
|
|
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Chemische Eigenschaften,Einsatz,Produktion Methoden |
Chemische Eigenschaften Brown Foam |
|
Verwenden A novel active metabolite of the anti-cancer drug Tamoxifen. It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast ca |
|
Verwenden A novel active metabolite of the anti-cancer drug Tamoxifen (T006000). It showed potent ER binding property, blocked estrogen stimulated growth of breast cancer cell and half maximal inhibition of estrogen responsive gene expression in ER pos. human breast cancer cell line. |
|
|
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Upstream-Materialien And Downstream Produkte |
Upstream-Materialien
|
Downstream Produkte
|
N-Desmethyl-4-hydroxy Tamoxifen (approx. 1:1 E/Z Mixture) Anbieter Lieferant Produzent Hersteller Vertrieb Händler. Global( 6)Lieferanten |
|
|
|
|